Hong Kong Stocks Decline Amid Tech Selloff; Shanghai Junshi Biosciences Slips on Oncology Venture

MT Newswires Live
06/08

Hong Kong stocks fell Monday as a technology-led selloff gathered pace after stronger-than-expected U.S. jobs data and renewed military tensions between Israel and Iran weighed on sentiment.

The Hang Seng Index shed 1.2%, or 304.89 points, to close at 24,657.06, while the Hang Seng China Enterprises Index lost 1.1%, or 95.27 points, to finish at 8,341.36.

The robust U.S. jobs report prompted traders to increase bets on a Federal Reserve rate hike later this year, triggering a selloff in technology stocks.

Markets are now pricing in a 72% probability of a rate hike by December, according to CME Group's FedWatch tool.

Meanwhile, Israel and Iran exchanged strikes for the first time since their ceasefire took effect, raising fresh doubts about the durability of the truce.

The escalation came after U.S. President Donald Trump said Sunday that renewed military action by either side would not derail Washington's peace talks with Tehran.

Brent crude rose more than $4 a barrel on Monday, extending gains as renewed hostilities heightened concerns over regional stability.

Shanghai Junshi Biosciences (HKG:1877, SHA:688180) closed 3% lower after saying it will contribute intellectual property and pre-clinical oncology assets to a newly established joint venture, Shanghai OnTarget Biopharmaceuticals, in exchange for a 14.55% stake.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10